Foresite Capital Management V, LLC
10% Owner
FundBuying only
- 2026
- Aug 11, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Foresite Capital Management V, LLC files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James B. Tananbaum - $2.52M in LTGO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Foresite Capital Management V, LLC?
Foresite Capital Management V, LLC is an investment firm, tracked as 10% Owner of Latigo Biotherapeutics, Inc. (LTGO). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Foresite Capital Management V, LLC submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Foresite Capital Management V, LLC been buying or selling stock?
Recorded transactions: 1 open-market purchase ($2.52M) and 0 open-market sales across all tracked filings.
